Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-04-24

Clinical Trial Update: The Effect of tDCS on Schizophrenia With Negative Symptoms [NA]

View source ↗

Summary

The clinical trial examining transcranial direct current stimulation (tDCS) for negative symptoms in schizophrenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Seoul National University Hospital | Conditions: Schizophrenia | NA | Status: WITHDRAWN